Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » New Understanding of Leukocyte Migration
Scientific Advances

New Understanding of Leukocyte Migration

By Will DossSep 24, 2020
Share
Facebook Twitter Email
William Muller, MD, PhD, the Janardan K. Reddy, MD Professor of Pathology, was senior author of the study published in the Journal of Experimental Medicine.

A recent Northwestern Medicine study published in the Journal of Experimental Medicine has revealed previously unknown details about calcium signaling that can contribute to inflammation.

These findings may help scientists better understand how to regulate inflammation, in an attempt to create new therapies for conditions such as inflammatory bowel disease and atherosclerosis, according to William A. Muller, MD, PhD, the Janardan K. Reddy, MD Professor of Pathology and senior author of the study.

“This paper shows for the first time how calcium signaling in endothelial cells, which is critical for inflammation under all conditions, is restricted in time and space,” said Muller, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “In the future, we want to explore how targeting endothelial-cell specific machinery can limit inflammation, but keep the body’s ability to respond to new inflammatory stimulus.”

Prarthana Dalal, a fourth year medical student in the Medical Scientist Training Program (MSTP) was first author of the study, and David Sullivan, PhD, research assistant professor of Pathology, was a co-author.

White blood cells, or leukocytes, are the body’s foot soldiers: patrolling the bloodstream, waiting for chemical alarms that trigger a coordinated charge to sites under attack. To do this, they must cross endothelial cells that line the blood vessels of the body.

Getting from the bloodstream into tissue requires the help of a membrane complex called the endothelial lateral border recycling compartment (LBRC), which surrounds the leukocytes and shepherds them across cell junctions and into tissue on the other side. Previous work in the Muller laboratory demonstrated that LBRC movement was triggered by calcium signaling, but the specifics of the mechanism were not clear, Muller said.

Leukocytes (red) migrate across blood vessels. Calcium signaling is shown in green.

To investigate, Muller and his collaborators bred mice whose endothelial cells glowed bright green in proportion to the concentration of free calcium ions in their cytoplasm. Then, the scientists gave these mice a bone marrow transplant from mice whose neutrophils, a specific type of white blood cell, glowed bright red. This allowed the investigators to track the inflammatory response and blood cell migration by microscopy as it unfolded in real time.

They discovered a self-contained process where molecules on the leukocyte engage molecules in the endothelial cell wall, leading to an increase in calcium flow that begins just as leukocytes start transmigration and ends just before they complete it.

“Calcium signaling happens all over the cell, so all parts of this signaling process are localized to the endothelial cell borders as to only trigger transmigration and not a whole other range of calcium signals,” Muller said.

These findings provide a better framework for modulating inflammation, which could be used to treat diseases of inflammation such as inflammatory bowel disease or atherosclerosis, according to Muller.

Current therapies block leukocytes throughout the body, which can have serious side effects. Instead, Muller envisions a drug that selectively targets the endothelial cells to decrease the amount of white blood cells getting through the endothelium, in the hopes of controlling excess inflammation while maintaining leukocyte function.

“Blocking endothelial-specific molecules that regulate transmigration is never 100 percent effective — that’s actually good news,” Muller said.

Using the example of Crohn’s disease, Muller said he hopes an endothelial migration-blocking drug could reduce the number of leukocytes traveling into the gut by 80 or 90 percent — enough to reduce symptoms locally, but not interfere with the function of the remaining leukocytes.

“This might be enough to manage patients’ diseases while not interfering with the body’s ability to respond to new inflammatory challenges,” Muller said.

This work was supported by National Institutes of Health grants R01HL046849, R01HL064774, T32GM8152, F30HL134202, NIH R01HL108932 and R01HL145459, and an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship.

Allergy & Immunology Pathology Research
Share. Facebook Twitter Email

Related Posts

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Comments are closed.

Latest News

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.